COVID-19 Incidence and Vaccine Effectiveness in University Staff, 1 March 2020–2 April 2022

COVID-19 Incidence and Vaccine Effectiveness in University Staff, 1 March 2020–2 April 2022

<b>Background</b>: University workers undergo intense social interactions due to frequent contact with students and colleagues and lectures in crowdy conditions. The aim of our study was to assess the incidence of COVID-19 infection and vaccine effectiveness in a cohort of workers of the...

Full description

Bibliographic Details
Main Authors:	Luca Cegolon, Corrado Negro, Marco Pesce, Francesca Larese Filon
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	Vaccines
Subjects:	SARS-CoV-2 COVID-19 incidence vaccine effectiveness booster dose university staff
Online Access:	https://www.mdpi.com/2076-393X/11/2/483

Similar Items

SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020–31 January 2023
by: Luca Cegolon, et al.
Published: (2023-07-01)

COVID-19 in City Council Civil Servants, 1 March 2020–31 January 2023: Risk of Infection, Reinfection, Vaccine Effectiveness and the Impact of Heterologous Triple Vaccination
by: Luca Cegolon, et al.
Published: (2024-02-01)

Primary SARS-CoV-2 Infections, Re-infections and Vaccine Effectiveness during the Omicron Transmission Period in Healthcare Workers of Trieste and Gorizia (Northeast Italy), 1 December 2021–31 May 2022
by: Luca Cegolon, et al.
Published: (2022-11-01)

Vaccine hesitancy for the COVID-19 vaccine booster dose among nursing home staff fully vaccinated with the primary vaccination course in Belgium
by: Marina Digregorio, et al.
Published: (2024-01-01)

Risk of Vaccine Breakthrough SARS-CoV-2 Infection and Associated Factors in Healthcare Workers of Trieste Teaching Hospitals (North-Eastern Italy)
by: Paolo Basso, et al.
Published: (2022-02-01)

SARS-CoV-2 Infection in Health Care Workers of Trieste (North-Eastern Italy), 1 October 2020–7 February 2022: Occupational Risk and the Impact of the Omicron Variant
by: Luca Cegolon, et al.
Published: (2022-07-01)

Incidence of COVID-19 infection in hospital workers from March 1, 2020 to May 31, 2021 routinely tested, before and after vaccination with BNT162B2
by: Francesca Larese Filon, et al.
Published: (2022-02-01)

Occupational Risk Factors for SARS-CoV-2 Infection in Hospital Health Care Workers: A Prospective Nested Case-Control Study
by: Alex Dusefante, et al.
Published: (2022-02-01)

Incidence and Determinants of Symptomatic and Asymptomatic SARS-CoV-2 Breakthrough Infections After Booster Dose in a Large European Multicentric Cohort of Health Workers-ORCHESTRA Project
by: Stefano Porru, et al.
Published: (2023-07-01)

IJCM_294A: COVID-19 vaccination status and willingness for booster dose among staff and students of tertiary care institute
by: Sharma Nikita, et al.
Published: (2024-04-01)

COVID-19 Booster Dose Coverage and Hesitancy among Older Adults in an Urban Slum and Resettlement Colony in Delhi, India
by: Nandini Sharma, et al.
Published: (2023-06-01)

Evolution of antibody profiles against SARS-CoV-2 in experienced and naïve vaccinated elderly people
by: Iván Sanz-Muñoz, et al.
Published: (2023-02-01)

Long COVID Prevalence and the Impact of the Third SARS-CoV-2 Vaccine Dose: A Cross-Sectional Analysis from the Third Follow-Up of the Borriana Cohort, Valencia, Spain (2020–2022)
by: Salvador Domènech-Montoliu, et al.
Published: (2023-10-01)

Determinants of the willingness of medical staff to vaccinate their children with a booster dose of the COVID-19 vaccine in Taizhou, China
by: Li-Li Huang, et al.
Published: (2022-11-01)

Effectiveness of the Booster Dose in Protecting against COVID-19, Colombia 2022
by: Jubby Marcela Gálvez, et al.
Published: (2023-09-01)

Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?
by: Vivek P. Chavda, et al.
Published: (2022-02-01)

Molnupiravir, Nirmatrelvir/Ritonavir, or Sotrovimab for High-Risk COVID-19 Patients Infected by the Omicron Variant: Hospitalization, Mortality, and Time until Negative Swab Test in Real Life
by: Luca Cegolon, et al.
Published: (2023-05-01)

Willingness to receive an annual COVID-19 booster vaccine in the German-speaking D-A-CH region in Europe: A cross-sectional study
by: Jakob Weitzer, et al.
Published: (2022-07-01)

Trends of COVID-19 incidence in Manitoba and public health measures: March 2020 to February 2022
by: Laila Aboulatta, et al.
Published: (2022-05-01)

Construction of an Index System of the Biosafety Incident Response Capability for Nursing Staff: A Delphi Study
by: Chao Wu, et al.
Published: (2025-01-01)

The pros and cons of the second booster dose of the COVID-19 vaccine
by: Ehsan Mostafavi
Published: (2022-08-01)

Is it the right time to introduce the hepatitis B booster vaccine in national immunization schedule? An analysis from the available evidence
by: Sudip Bhattacharya, et al.
Published: (2021-01-01)

Comparative Analysis of Primary and Monovalent Booster SARS-CoV-2 Vaccination Coverage in Adults with and without HIV in Catalonia, Spain
by: Daniel Kwakye Nomah, et al.
Published: (2023-12-01)

Intention and hesitancy to receive a booster dose of COVID-19 vaccine among pregnant women using a health belief model: A cross-sectional study
by: Anmar Al-Taie, et al.
Published: (2023-01-01)

Immunogenicity and safety of RAZI recombinant spike protein vaccine (RCP) as a booster dose after priming with BBIBP-CorV: a parallel two groups, randomized, double blind trial
by: Saeed Erfanpoor, et al.
Published: (2024-02-01)

Neutralizing Antibodies against the SARS-CoV-2 Delta and Omicron BA.1 following Homologous CoronaVac Booster Vaccination
by: Jianhua Li, et al.
Published: (2022-12-01)

A population-based assessment of myocarditis after messenger RNA COVID-19 booster vaccination among adult recipients
by: Zaeema Naveed, et al.
Published: (2023-06-01)

Antibody response following the third and fourth SARS-CoV-2 vaccine dose in individuals with common variable immunodeficiency
by: Bibi Uhre Nielsen, et al.
Published: (2022-07-01)

The Effectiveness of the Disaster Plan on the Incidence of COVID-19 in Emergency Department Staff of King Abdulaziz Medical City in Western Region
by: Maan Jamjoom, et al.

THE RESULTS OF INDIVIDUAL DOSE CONTROL OF HEALTH INSTITUTIONS STAFF
by: E. N. Shleenkova
Published: (2015-08-01)

Effectiveness of Sinopharm’s BBIBP-CorV Booster Vaccination against COVID-19-Related Severe and Critical Cases and Deaths in Morocco during the Omicron Wave
by: Jihane Belayachi, et al.
Published: (2024-02-01)

Hesitancy towards COVID-19 booster vaccine among healthcare workers in Bangladesh
by: Homayra Rahman Shoshi, et al.
Published: (2025-03-01)

Current epidemiological characteristics of pertussis in the Russian Federation
by: A. V. Stepenko, et al.
Published: (2020-06-01)

Covid-19 Vaccine Booster Dose and The Indian Scenario: When We Will Have a Fully Immunized Population?
by: Amitesh Datta, et al.
Published: (2023-09-01)

“Booster Vaccine” to Mitigate the Threat of “Emerging COVID-19 Variants” A short Review
by: Mahalakshmi Pandian, et al.
Published: (2021-10-01)

Sporadic Emergence of Probable Cases of Diphtheria
by: Fajolu IB, et al.
Published: (2024-07-01)

Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study
by: Walid Al-Qerem, et al.
Published: (2022-03-01)

Fourth dose of COVID-19 vaccine: Does it still contribute any additional immunoprotection?
by: Rujittika Mungmunpuntipantip, PhD, et al.
Published: (2022-06-01)

A review of SARS-CoV-2 variants and vaccines: Viral properties, mutations, vaccine efficacy, and safety
by: Md. Aminul Islam
Published: (2023-12-01)

SARS-CoV-2 booster vaccine dose significantly extends humoral immune response half-life beyond the primary series
by: Chapin S. Korosec, et al.
Published: (2024-04-01)